Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
Authors:
- Regina KatzenschlagerRKRegina Katzenschlager
- Werner PoeweWPWerner Poewe
- Olivier RascolOROlivier Rascol
- Claudia TrenkwalderCTClaudia Trenkwalder
- Günther DeuschlGDGünther Deuschl
- K Ray ChaudhuriK Ray Chaudhuri
- Tove HenriksenTHTove Henriksen
- Teus van LaarTLTeus van Laar
- Harry StainesHSHarry Staines
- Andrew LeesALAndrew Lees
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 83, 79-85
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trialThe Lancet Neurology, 2018
- Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up studyParkinsonism & Related Disorders, 2017
- Apomorphine - pharmacological properties and clinical trials in Parkinson's diseaseParkinsonism & Related Disorders, 2016
- Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patientsParkinsonism & Related Disorders, 2016
- Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendationsParkinsonism & Related Disorders, 2015
- Apomorphine hydrochloride for the treatment of Parkinson’s diseaseExpert Review of Neurotherapeutics, 2015
- Effective Delivery of Apomorphine in the Management of Parkinson DiseaseClinical Neuropharmacology, 2015
- Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter studyMovement Disorders, 2008
- Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patientsMovement Disorders, 2002
- Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow upJournal of Neurology, Neurosurgery & Psychiatry, 1998